Healthcare

Needham’s healthcare practice covers a wide breadth of subsectors within biotechnology, biopharmaceuticals, medical technology, diagnostics, and techbio, including AI drug discovery. Therapeutic indications of focus include, but are not limited to: autoimmune, cardiovascular, dermatology, fibrosis, gastrointestinal, hematology, infectious, inflammation & immunology, metabolic, neuroscience, oncology, ophthalmology, orphan, pain, pulmonary and renal diseases. Modalities of focus include, but are not limited to: small molecules, biologics, ADCs, ASOs, cell therapies, gene therapies, peptides, protein degraders, radiopharmaceuticals, RNA, and vaccines.

Recent Transactions

Oct 2026
$575M
company logo
Convertible

Lead Manager

Aug 2026
$40M
company logo
Follow-On Offering

Co-Manager

May 2026
$150M
company logo
Registered Direct Offering

Lead Manager

May 2026
$300M
company logo
Registered Direct Offering

Lead Manager

May 2026
$805M
company logo
Follow-On Offering

Co-Manager

May 2026
$150M
company logo
Follow-On Offering

Lead Manager

Contacts

Simon Gill
Managing Director, Co-Head of Healthcare Investment Banking
Full Bio
Rich Haerle
Managing Director, Head of Healthcare Equity Capital Markets
Full Bio
Carolyn Horn
Managing Director, Co-Head of Healthcare Investment Banking
Full Bio
Matthew Wagner
Managing Director
Full Bio
Joe Stokes
Principal
Full Bio